175 related articles for article (PubMed ID: 20856830)
1. Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone.
Balint B; Watz H; Amos C; Owen R; Higgins M; Kramer B;
Int J Chron Obstruct Pulmon Dis; 2010 Sep; 5():311-8. PubMed ID: 20856830
[TBL] [Abstract][Full Text] [Related]
2. Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease.
Vogelmeier C; Magnussen H; LaForce C; Owen R; Kramer B
Ther Adv Respir Dis; 2011 Oct; 5(5):345-57. PubMed ID: 21719531
[TBL] [Abstract]
